4.8 Article

Cooperative genomic alteration network reveals molecular classification across 12 major cancer types

Journal

NUCLEIC ACIDS RESEARCH
Volume 45, Issue 2, Pages 567-582

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw1087

Keywords

-

Funding

  1. National High Technology Research and Development Program of China (863 Program) [2014AA021102]
  2. National Program on Key Basic Research Project (973 Program) [2014CB910504]
  3. National Natural Science Foundation of China [91439117, 61473106, 61573122]
  4. Wu lienteh youth science fund project of Harbin medical university [WLD-QN1407]
  5. Key Laboratory of Cardiovascular Medicine Research (Harbin Medical University), Ministry of Education
  6. Funds for the Graduate Innovation Fund of Heilongjiang Province [YJSCX2015-8HYD]

Ask authors/readers for more resources

The accumulation of somatic genomic alterations that enables cells to gradually acquire growth advantage contributes to tumor development. This has the important implication of the widespread existence of cooperative genomic alterations in the accumulation process. Here, we proposed a computational method HCOC that simultaneously consider genetic context and downstream functional effects on cancer hallmarks to uncover somatic cooperative events in human cancers. Applying our method to 12 TCGA cancer types, we totally identified 1199 cooperative events with high heterogeneity across human cancers, and then constructed a pan-cancer cooperative alteration network. These cooperative events are associated with genomic alterations of some highconfident cancer drivers, and can trigger the dysfunction of hallmark associated pathways in a codefect way rather than single alterations. We found that these cooperative events can be used to produce a prognostic classification that can provide complementary information with tissue-of-origin. In a further case study of glioblastoma, using 23 cooperative events identified, we stratified patients into molecularly relevant subtypes with a prognostic significance independent of the Glioma-CpG Island Methylator Phenotype (GCIMP). In summary, our method can be effectively used to discover cancer-driving cooperative events that can be valuable clinical markers for patient stratification.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available